Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease

MLA

Chauvelot, Louis, et al. “Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.” Arthritis & Rheumatology, vol. 73, no. 2, Feb. 2021, pp. 295–304. EBSCOhost, https://doi.org/10.1002/art.41512.

APA

Chauvelot, L., Gamondes, D., Berthiller, J., Nieves, A., Renard, S., Catella, C. J., Ahmad, K., Bertoletti, L., Camara, B., Gomez, E., Launay, D., Montani, D., Mornex, J., Prévot, G., Sanchez, O., Schott, A., Subtil, F., Traclet, J., Turquier, S., & Zeghmar, S. (2021). Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease. Arthritis & Rheumatology, 73(2), 295–304. https://doi.org/10.1002/art.41512

Chicago

Chauvelot, Louis, Delphine Gamondes, Julien Berthiller, Ana Nieves, Sébastien Renard, Chatron, Judith Catella, Kais Ahmad, et al. 2021. “Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.” Arthritis & Rheumatology 73 (2): 295–304. doi:10.1002/art.41512.